1 detailed study records

Key findings from detailed records

In a small crossover study, 3 g glycine before bed during 3 nights of restricted sleep improved selected next-day vigilance measures. Fatigue improved on day 1, not day 3. Only 7 healthy men were analyzed.

KNOWLEDGE RECORD

Category
Sleep and stress
Last Reviewed

Names and related search termsGlycine / Glycine

Study type: small exploratory studies.

Explore 10 papers by research question ↓

OUTCOME-SPECIFIC EVIDENCE

Scientific Evidence Profile

Assessment pending

An outcome-specific assessment has not yet been completed. This is not a finding that the ingredient is ineffective. The study records below remain available.

This profile concerns the stated outcome and population, not the ingredient as a whole. It is not a probability of benefit, a safety rating, a product efficacy rating or an indication of product adoption.

How we assess evidence

Ingredient Profile

What is it?
Glycine is the simplest protein-forming amino acid. Unlike the other standard amino acids, it has no asymmetric carbon centre. [1]
Sources for this profile

Compound properties and formulation properties are different. These sources do not establish the efficacy of a finished supplement.

  1. PubChem — Glycine (CID 750) Chemical identity reference. Maintained by NCBI, U.S. National Library of Medicine. Database record; not a clinical trial.

Profile sources checked:

Read the evidence in context
  • Evidence: what was measured in the stated population or experimental model.
  • Inference: an interpretation connecting findings; its applicability depends on the study conditions.
  • Hypothesis: a proposed explanation or effect that remains to be tested.

Research Evidence · Scientific Synthesis

Why It Matters #

Does glycine change next-day fatigue during short-term sleep restriction? Check the detailed records for study conditions and use the literature map to compare other populations and outcomes.

What Was Studied #

10 healthy male participants, with 7 analyzed; employees of Ajinomoto. Single-blind, randomized crossover trial. Outcomes: Next-day sleepiness, fatigue and performance tasks. Prespecified primary/secondary classification was not verified.[1]

What Was Found #

Subjective fatigue improved on day 1, but not day 3. Psychomotor vigilance improved on both days under the study’s sleep-restriction conditions.[1]

What the Evidence Means #

Very small, short-term and single-blind. It does not establish treatment for chronic insomnia or long-term sleep improvement.[1]

Comparing similar populations, formulations, durations and outcomes helps identify where findings agree and where they differ.

What We Can Learn #

Read this as preliminary human sleep evidence. This selected study alone does not justify an “S” rating or a claim of high reproducibility.

What Remains Unknown #

Further questions include reproducibility across populations and formulations, and the long-term balance of benefits and harms. Use the literature map as a starting point for these questions.

LITERATURE MAP / 10 PAPERS

Compare papers by conditions and findings.

Distinguish glycine alone from combinations with cysteine or NAC. Sleep, metabolism and adjunctive use in psychiatric conditions address different questions.

Selected: 2026-09-21. Bibliographic information checked against Europe PMC / PubMed. Editorial selection considered major papers and a range of populations and questions. This is not a systematic search covering all recent research.

10 RECORDS

A dash marks fields outside the bibliographic record. Use detailed records to compare findings and design records to connect mechanisms.

Research comparison table
Paper and topicStudy conditionsFindings and scope
Sleep and moodThe effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers.2012 Frontiers in neurologyPMID 22529837 #Study conditions

Single-blind, randomized crossover trial

Population
10 healthy male participants, with 7 analyzed; employees of Ajinomoto.
Dose
3 g 30 minutes before bedtime versus placebo
Duration
3 nights per condition, with time in bed reduced by 25% from usual.
Outcomes
Next-day sleepiness, fatigue and performance tasks. Prespecified primary/secondary classification was not verified.
Findings and scope

Subjective fatigue improved on day 1, but not day 3. Psychomotor vigilance improved on both days under the study’s sleep-restriction conditions.

View findings and limitations

DOI

Authors

Bannai M, Kawai N, Ono K, Nakahara K, Murakami N

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.1999 Archives of general psychiatryPMID 9892253 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M

The metabolic response to ingested glycine.2002 The American journal of clinical nutritionPMID 12450897 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Gannon MC, Nuttall JA, Nuttall FQ

Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation.2011 The American journal of clinical nutritionPMID 21795440 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE et al.

Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine.2011 Diabetes carePMID 20929994 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Sekhar RV, McKay SV, Patel SG, Guthikonda AP, Reddy VT, Balasubramanyam A et al.

Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial.2021 Clinical and translational medicinePMID 33783984 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F et al.

Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial.2023 The journals of gerontology. Series A, Biological sciences and medical sciencesPMID 35975308 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F et al.

Placebo-controlled trial of glycine added to clozapine in schizophrenia.2000 The American journal of psychiatryPMID 10784481 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Evins AE, Fitzgerald SM, Wine L, Rosselli R, Goff DC

Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes.2008 Journal of endocrinological investigationPMID 18852529 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Cruz M, Maldonado-Bernal C, Mondragón-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G et al.

Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure.2013 Canadian journal of physiology and pharmacologyPMID 24144057 #Study conditions

—

Findings and scope

—

Open original paper

DOI

Authors

Díaz-Flores M, Cruz M, Duran-Reyes G, Munguia-Miranda C, Loza-Rodríguez H, Pulido-Casas E et al.

The literature map is an index of research questions and references. Individual assessment of results, doses, funding and COI is limited to the detailed study records. Related reports from the same trial may be included; paper counts are not counts of independent trials.

Explore the research Study Records

Listed doses describe study conditions, not recommended intake.

Study RecordPMID 22529837

The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers.

Authors
Bannai M, Kawai N, Ono K, Nakahara K, Murakami N.
Journal
Frontiers in neurology
Publication year
2012
Study design
Single-blind, randomized crossover trial
Participants
10 healthy male participants, with 7 analyzed; employees of Ajinomoto.
Dose and intervention
3 g 30 minutes before bedtime versus placebo
Duration
3 nights per condition, with time in bed reduced by 25% from usual.
Outcomes and their role in the study
Next-day sleepiness, fatigue and performance tasks. Prespecified primary/secondary classification was not verified.
Findings
Subjective fatigue improved on day 1, but not day 3. Psychomotor vigilance improved on both days under the study’s sleep-restriction conditions.
Limitations
Very small, short-term and single-blind. It does not establish treatment for chronic insomnia or long-term sleep improvement.
Funding
Partly supported by PROBRAIN, the Program for Promotion of Basic Research Activities for Innovative Bioscience.
Conflict of Interest
The authors declared no commercial or financial conflicts. Author affiliations included Ajinomoto, and the human volunteers were Ajinomoto employees; these study relationships are relevant context.
Scope of source review
Primary-paper methods, relevant results, limitations and funding/COI checked on 2026-10-24. This record assesses the stated claims, not every analysis in the paper.

Cite this page

LÍFSVARÐA. Glycine: Does glycine change next-day fatigue during short-term sleep restriction? Version 1.1 / Updated 2026-10-24

https://lifsvarda.com/knowledge/glycine/

Edited by LÍFSVARÐA (product brand).Editorial policy

Sources and updates

  1. Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. (2012). The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers.Primary-paper methods, relevant results, limitations and funding/COI checked on 2026-10-24. This record assesses the stated claims, not every analysis in the paper.

First published: 2026-09-21 / Version 1.1. Updated 2026-09-23: Added a research comparison table and links to design records. Source notes identify the scope of verification when the full paper has not been reviewed. Research summaries and LÍFSVARÐA’s interpretation are distinguished.